Clinical Implications of Percutaneous Coronary Intervention-Clopidogrel in Unstable angina to prevent Recurrent Events (PCI-CURE) Study
- 22 October 2002
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 106 (17), 2284-2287
- https://doi.org/10.1161/01.cir.0000035924.70846.20
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Cost Effectiveness of Aspirin, Clopidogrel, or Both for Secondary Prevention of Coronary Heart DiseaseNew England Journal of Medicine, 2002
- Does ticlopidine reduce reocclusion and other adverse events after successful balloon angioplasty of occluded coronary arteries? Results from the Total Occlusion Study of Canada (TOSCA)American Heart Journal, 2001
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationNew England Journal of Medicine, 2001
- Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE studyThe Lancet, 2001
- Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary RevascularizationNew England Journal of Medicine, 2001
- Ticlopidine Pretreatment Before Coronary Stenting Is Associated With Sustained Decrease in Adverse Cardiac EventsCirculation, 2001
- Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trialThe American Journal of Cardiology, 2001
- The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular diseasePublished by Oxford University Press (OUP) ,2000
- Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement.Circulation, 1999
- The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non–Q-wave myocardial infarctionsJournal of the American College of Cardiology, 1998